Modulating the polarization phenotype of microglia - A valuable strategy for central nervous system diseases

Yu Long1, Xiao-Qiu Li1, Jie Deng1

  • 1State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

Ageing Research Reviews
|December 8, 2023
PubMed

Insights

Central nervous system (CNS) diseases are a major global health concern. Understanding microglia polarization (M1/M2) and therapeutic modulation strategies is key to developing new treatments for CNS disorders.

Area of Science:

  • Neuroscience
  • Immunology

Background:

  • Central nervous system (CNS) diseases are a leading cause of global mortality.
  • The complex pathogenesis necessitates improved treatment strategies.
  • Microglia, immune cells in the CNS, exhibit dual roles (harmful/beneficial) in disease progression.

Purpose of the Study:

  • To elucidate the roles of M1 and M2 microglia phenotypes in CNS diseases.
  • To explore microglia's involvement in intercellular communication and pathological responses.
  • To review current strategies for modulating microglia polarization.

Main Methods:

  • Literature review focusing on microglia polarization in CNS diseases.
  • Analysis of M1 and M2 microglia functions.
  • Compilation of therapeutic modulation approaches.

Main Results:

  • Microglia polarization into M1 (pro-inflammatory) and M2 (anti-inflammatory) phenotypes influences CNS disease outcomes.
  • M1/M2 phenotypes differentially regulate intercellular dialogues and pathological reactions.
  • Various strategies exist to modulate microglia polarization.

Conclusions:

  • Understanding microglia polarization is crucial for CNS disease treatment.
  • Modulating microglia phenotypes offers potential therapeutic avenues.
  • This review provides insights into novel treatment strategies for CNS diseases.